|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
5 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues (Note 17) | |||||
| Services | |||||
| Products | |||||
| Total revenues (Note 17) | |||||
| Cost of sales | |||||
| Services | |||||
| Products | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Selling and administrative expense | |||||
| Research, development and engineering expense | |||||
| Impairment of assets | |||||
| (Gain) loss on sale of assets, net | |||||
| Impairment of assets and other | |||||
| Total costs and expenses | |||||
| Operating profit (loss) | |||||
| Other income (expense) | |||||
| Interest income | |||||
| Interest expense | |||||
| Foreign exchange gain (loss), net | |||||
| Reorganization items, net | |||||
| Miscellaneous, net | |||||
| Loss on extinguishment of debt | |||||
| Loss on refinancing | |||||
| Income (loss) before taxes | |||||
| Income tax expense (benefit) | |||||
| Equity in earnings (loss) of unconsolidated subsidiaries, net | |||||
| Net income (loss) | |||||
| Net income (loss) income attributable to noncontrolling interests | |||||
| Net income (loss) attributable to Diebold Nixdorf | |||||
| Basic weighted-average shares outstanding (in shares) | |||||
| Diluted weighted-average shares outstanding (in shares) | |||||
| Net income (loss) attributable to Diebold Nixdorf | |||||
| Basic earnings (loss) per share (in dollars per share) | |||||
| Diluted earnings (loss) per share (in dollars per share) | |||||
Loading...